{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:17:25Z","timestamp":1776943045309,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ymgme.2022.03.002","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:44:53Z","timestamp":1646826293000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term efficacy and safety of vestronidase alfa enzyme replacement therapy in pediatric subjects &lt; 5 years with mucopolysaccharidosis VII"],"prefix":"10.1016","volume":"136","author":[{"given":"Heather A.","family":"Lau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Viskochil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranoot","family":"Tanpaiboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Gonzalez-Meneses","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmeralda","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betsy","family":"Malkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Jurecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2022.03.002_bb0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3476(73)80162-3","article-title":"Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis","volume":"82","author":"Sly","year":"1973","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0015","series-title":"VII BioDrugs","first-page":"233","article-title":"Vestronidase alfa: a review in mucopolysaccharidosis","volume":"33","author":"McCafferty","year":"2019"},{"key":"10.1016\/j.ymgme.2022.03.002_bb0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/humu.20828","article-title":"Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly syndrome)","volume":"30","author":"Tomatsu","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0025","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/uog.20371","article-title":"Association between mucopolysaccharidosis type VII and hydrops fetalis","volume":"55","author":"Holtz","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0035","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2022.03.002_bb0040","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2020.06.004","article-title":"Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses","volume":"130","author":"Jones","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2018.03.004","article-title":"Growth impairment in mucopolysaccharidoses","volume":"124","author":"Melbouci","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0060","first-page":"45","article-title":"Bioimpedance analysis as a method to evaluate the proportion of fatty and muscle tissues in progressive myopathy in Pompe disease","volume":"26","author":"R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska","year":"2016","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0065","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of Sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Monta\u00f1o","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0070","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1172\/JCI1773","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function","volume":"101","author":"O\u2019Connor","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0075","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1023\/A:1005423222927","article-title":"Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease","volume":"21","author":"Vogler","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0080","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1203\/00006450-199606000-00019","article-title":"Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival","volume":"39","author":"Vogler","year":"1996","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ymgme.2018.02.006","article-title":"A novel blind start study design to investigate vestronidase alfa for mucopolysaccharidosis VII, an ultra-rare genetic disease","volume":"123","author":"Harmatz","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2020.01.003","article-title":"The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII","volume":"129","author":"Wang","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12881-016-0284-4","article-title":"12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment","volume":"17","author":"Gabrielli","year":"2016","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0100","first-page":"99","article-title":"Enzyme replacement therapy in mucopolysaccharidosis II patients under 1 year of age","volume":"14","author":"Lampe","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpeds.2016.08.033","article-title":"Outcomes of long-term treatment with laronidase in patients with mucopolysaccharidosis type I","volume":"178","author":"Laraway","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age\u2014a sibling control study","volume":"77","author":"McGill","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ymgme.2012.12.010","article-title":"Effects of idursulfase enzyme replacement therapy for mucopolysaccharidosis type II when started in early infancy: comparison in two siblings","volume":"108","author":"Tajima","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0120","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1651-2227.2011.02385.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up","volume":"101","author":"Tylki-Szymanska","year":"2012","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0125","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2214\/ajr.157.1.2048509","article-title":"Normal splenic size in infants and children: sonographic measurements","volume":"157","author":"Rosenberg","year":"1991","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0130","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s13312-010-0090-6","article-title":"Normal values of liver and spleen size by ultrasonography in Indian children","volume":"47","author":"Dhingra","year":"2010","journal-title":"Ind. Pediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0135","first-page":"28","article-title":"The clinical global impressions scale: applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont.)"},{"key":"10.1016\/j.ymgme.2022.03.002_bb0140","series-title":"Bayley Scales of Infant and Toddler Development","author":"Bayley","year":"2006"},{"key":"10.1016\/j.ymgme.2022.03.002_bb0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80501-1","article-title":"Clinical longitudinal standards for height and height velocity for North American children","volume":"107","author":"Tanner","year":"1985","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.clinbiochem.2014.06.012","article-title":"Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population","volume":"47","author":"Komosinska-Vassev","year":"2014","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0155","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3476(75)80968-1","article-title":"Variation in the phenotypic expression of \u03b2-glucuronidase deficiency","volume":"86","author":"Beaudet","year":"1975","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0160","first-page":"216","article-title":"Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly","volume":"33","author":"Gillett","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpedi.1985.02140030059029","article-title":"Beta-glucuronidase deficiency. A heterogeneous mucopolysaccharidosis","volume":"139","author":"Lee","year":"1985","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ymgme.2022.03.002_bb0170","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1542\/peds.2008-0635","article-title":"Lysosomal storage disorders in the newborn","volume":"123","author":"Staretz-Chacham","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2022.03.002_bb0175","first-page":"457","article-title":"Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII","volume":"58","author":"Vervoort","year":"1996","journal-title":"Am. J. Hum. Genet."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:51:34Z","timestamp":1761090694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222001536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1096719222001536"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.03.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy and safety of vestronidase alfa enzyme replacement therapy in pediatric subjects < 5 years with mucopolysaccharidosis VII","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}